These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22946026)

  • 1. Vasostatin increases oxygenation of B16-F10 melanoma tumors and raises therapeutic efficacy of cyclophosphamide.
    Cichoń T; Jarosz M; Smolarczyk R; Ogórek B; Matuszczak S; Wagner M; Mitrus I; Sochanik A; Jazowiecka-Rakus J; Szala S
    Acta Biochim Pol; 2012; 59(3):377-81. PubMed ID: 22946026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of vasostatin and cyclophosphamide in the therapy of murine melanoma tumors.
    Jazowiecka-Rakus J; Jarosz M; Kozłowska D; Sochanik A; Szala S
    Acta Biochim Pol; 2007; 54(1):125-33. PubMed ID: 17369879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours.
    Jazowiecka-Rakus J; Jarosz M; Szala S
    Acta Biochim Pol; 2006; 53(1):199-202. PubMed ID: 16388313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A; Mitrus I; Smolarczyk R; Cichoń T; Snietura M; Czaja M; Szala S
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):235-45. PubMed ID: 20383751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of IL-12 gene therapy and CTX chemotherapy inhibits growth of primary B16(F10) melanoma tumors in mice.
    Mitrus I; Delić K; Wróbel N; Missol-Kolka E; Szala S
    Acta Biochim Pol; 2006; 53(2):357-60. PubMed ID: 16733559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
    Hermans IF; Chong TW; Palmowski MJ; Harris AL; Cerundolo V
    Cancer Res; 2003 Dec; 63(23):8408-13. PubMed ID: 14679003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
    Kalland T
    Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
    Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
    Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
    Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
    Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
    Leibovici J; Kopel S; Wolman M
    Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
    Xiao F; Wei Y; Yang L; Zhao X; Tian L; Ding Z; Yuan S; Lou Y; Liu F; Wen Y; Li J; Deng H; Kang B; Mao Y; Lei S; He Q; Su J; Lu Y; Niu T; Hou J; Huang MJ
    Gene Ther; 2002 Sep; 9(18):1207-13. PubMed ID: 12215887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
    Zheng LM; Li Z; Liu L; Song BL; King I
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of monotherapy and combined therapy with NSC-631570 (ukrain) on growth of low- and high-metastasizing B16 melanoma in mice.
    Skivka L; Susak Y; Trompak O; Kudryavets Y; Bezdeneznikh N; Semesiuk N; Lykhova O
    J Oncol Pharm Pract; 2011 Dec; 17(4):339-49. PubMed ID: 20817651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumors.
    Mitrus I; Sochanik A; Cichoń T; Szala S
    Acta Biochim Pol; 2009; 56(1):161-5. PubMed ID: 19287800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.
    Cao X; Zhang W; Wan T; Yu Y; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):173-9. PubMed ID: 10464704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.
    Curnis F; Sacchi A; Corti A
    J Clin Invest; 2002 Aug; 110(4):475-82. PubMed ID: 12189241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of mesna with cyclophosphamide or adriamycin in the treatment of mice with tumors.
    Bernacki RJ; Bansal SK; Gurtoo HL
    Cancer Res; 1987 Feb; 47(3):799-802. PubMed ID: 3100025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.